Mrs. Laura Elizabeth Keeney, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13609 Devonbrook Rd, Baldwin, MD 21013 Phone: 410-598-9914 |
Mrs. Maureen Sullivan Evans, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2608 Stanley Dr, Baldwin, MD 21013 Phone: 443-243-3628 |
Judith Ann Heller, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13 Manor Knoll Ct, Baldwin, MD 21013 Phone: 410-952-3724 |
News Archive
A new American Cancer Society study finds that recent progress in closing the gap in overall cancer mortality between African Americans and whites may be due primarily to smoking-related cancers, and that cancer mortality differences related to screening and treatment may still be increasing.
Medtronic, Inc. has announced the start of ENGAGE, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.
Even though there are definitive guidelines to diagnose IBS through simple blood tests, many IBS patients have additional procedures and surgeries that rarely result in relief or any additional diagnostic findings.
I was the obstetrician on hospital duty that Sunday morning, so I introduced myself and learned that the patient, pregnant with her first child, wished to have as few interventions as possible. Respecting her desire, we decided to reevaluate her in a few hours to see how her labor had progressed. But would she get her wish? ... the odds were greater than 1 in 4 that this woman would end up not with the natural delivery she wanted, but with a surgical delivery in one of the two operating rooms down the hall.
Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.
› Verified 6 days ago